Lifestyle Intervention for Sustained Remissio...

Interview with Robert Goulden, MBBS author of Magnesium Supplementation and Tachyarrhythmias:A Nonrandomized Clinical Trial and Jason H. Wasfy, MD, MPhil author of Evidence for Clinical Treatment Decisions Without Randomized Data. Hosted by Ilana Richman, MD MHS. Related Content: ...  Show more

Interview with Sammy Saab, MD, MPH, author of Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review. Hosted by Eve Rittenberg, MD. Related Content: Targeting MASLD and MASH in the US Hispanic/Latino Population 

Interview with Bradley J. Katz, MD, PhD, author of Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide. Hosted by Neil Bressler, MD. Related Content: Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatid ...  Show more

Contributor: Travis Barlock MD

Educational Pearls:

How do you differentiate between compensated and decompensated cirrhosis?

Use the acronym VIBE to look for signs o ...

By the end of this episode you will be able to: Describe the anatomy and physiology of the liver Outline the pathophysiology and common symptoms of liver failure Explain how to assess and treat a patient with cirrhosis 

<div>Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as Non-alcoholic fatty liver disease (NAFLD), is estimated to affect up to 1 in 5 people in the UK. Rates are increasing with rising levels of obesity. Although most cases of MASLD are linked to exc ...  Show more